Read + Share
Amedeo Smart
Independent Medical Education
Goss CH, Fajac I, Jain R, Seibold W, et al. Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study. Eur Respir J 2022;59.PMID: 34385272
Email
LinkedIn
Facebook
Twitter
Privacy Policy